Zolpidem Tartrate Tablet
Product Images NDC 60760-515

4 FDA label images from St. Mary's Medical Park Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 60760-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (Structure)

Image 1 (Structure)
Chemical structure of zolpidem tartrate showing the molecular arrangement of zolpidem and tartrate components as illustrated in the diagram.*
FDA Label Image
FDA Label Image
FDA Label Image

515 (Zolpidem 60760 515 30)

515 (Zolpidem 60760 515 30)
The label for Zolpidem Tartrate Tablets, USP 5 mg, oral dosage form, containing 30 tablets. The label shows manufacturing by Piramal Pharma Limited in India and packaging by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. It includes space for NDC 60760-515-30, lot number, expiration date, and Rx number, with instructions to use as directed and store at 20°-25°C (68°-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.